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Objectives: Both hypothermia and ischemic preconditioning are known to
provide tolerance to myocardial ischemia and reperfusion. The aim of this
study was to determine whether hypothermia during the ischemic precon-
ditioning period attenuates the protective effect of ischemic precondition-
ing. Methods: Experiments were performed in buffer-perfused isolated
rabbit hearts. All hearts underwent 45 minutes of regional ischemia,
followed by 2 hours of reperfusion. Ischemic preconditioning was elicited by
either one or four periods of 5 minutes of regional ischemia. Hypothermia
(25° C) was induced beginning either 20 or 50 minutes before the 45-minute
period of regional ischemia; normothermia (38° C) was restored 10 minutes
before the 45-minute period of regional ischemia. Except for the hypother-
mic periods noted, hearts were maintained at 38° C. Results: Normothermic
ischemic preconditioning with either one or four cycles of 5 minutes of
coronary occlusion resulted in a profound reduction of infarct size (58%
reduction with one cycle, p < 0.05; 95% reduction with four cycles, p <
0.01). Hypothermic ischemic preconditioning with one cycle of 5-minute
coronary occlusion resulted in no reduction of infarct size but hypothermic
ischemic preconditioning with four cycles of 5-minute coronary occlusions
resulted in a 94% reduction of infarct size (p < 0.01). Myocardial glycogen
and lactate levels were maintained near control levels during hypothermic
ischemia. Conclusions: From these data we conclude that hypothermia
during the preconditioning period increases the threshold for eliciting the
infarct limitation of ischemic preconditioning. (J Thorac Cardiovasc Surg
1998;116:319-26)
Clinically, organ preservation during ischemia re-lies heavily on hypothermia. Moderate to pro-
found hypothermia prolongs organ survival during
global ischemia,1 and induced hypothermia is com-
mon for procedures requiring cardiopulmonary by-
pass.2 Cardiac hypothermia decreases myocardial
oxygen consumption, slows the rate of ischemic
adenosine triphosphate depletion, and reduces in-
farct size.1, 2
Experimentally, ischemic preconditioning (i.e.,
one or more transient periods of sublethal ischemia)
also provides profound tolerance to subsequent
ischemic episodes.3 Ischemic preconditioning can be
elicited either by total coronary occlusion3, 4 or by
low-flow ischemia5; however, in both cases marked
ischemia must be present for at least 5 minutes to
elicit the phenomenon.4, 5 To date, all animal spe-
cies tested have displayed the preconditioning phe-
nomenon, and there is evidence that precondition-
ing can be elicited in human myocardium.6 Yet
there has been relatively little investigation of isch-
emic preconditioning in a hypothermic environment
or in hypothermic tissues. Cave and Hearse7 dem-
onstrated that the preconditioning-induced preser-
vation of postischemic contractile function was
achieved with a normothermic preconditioning stim-
ulus and a hypothermic long ischemic period. How-
ever, the effect of hypothermia during the precon-
ditioning ischemia is unknown. We postulated that
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hypothermia may reduce myocardial energy de-
mand such that a typical preconditioning stimulus is
insufficient to generate the depth of ischemia re-
quired to elicit the preconditioning phenomenon.
The primary goal of this study was to clarify the
effect of temperature during the preconditioning
period on infarct size. Additionally, the metabolic
effects of hypothermia during preconditioning were
evaluated by measurement of myocardial glycogen
and lactate levels. Experiments were performed in
buffer-perfused isolated rabbit hearts undergoing
regional ischemia-reperfusion. Rabbits were chosen
for this study because their lack of coronary collat-
erals simplifies infarct size analysis; isolated hearts
were used to facilitate rapid and precise changes in
temperature.
Methods
Animals used in this study were allowed access to food
and water ad libitum until induction of anesthesia. All
animals received humane treatment in compliance with
both the “Guide for the Care and Use of Laboratory
Animals” published by the National Institutes of Health
(NIH Publication No. 86-23, revised 1985) and local
institutional policy.
Experimental preparation. Male New Zealand White
rabbits (2.5 to 3.0 kg) were anesthetized with 30 mg/kg
sodium pentobarbital plus 10 mg supplements of intrave-
nous pentobarbital as needed. After tracheostomy, all
rabbits received mechanical ventilation (MDI ventilator,
Mobile, Ala.). A left thoracotomy was performed in the
fourth intercostal space and the pericardium was opened
to expose the heart. A 4-0 silk ligature was placed around
the proximal segment of a major left coronary artery to
form a snare.
The hearts were then rapidly excised, placed in saline
solution for transport, and mounted on a nonrecirculating
Langendorff apparatus. Excision, mounting, and restora-
tion of perfusion were performed in less than 60 seconds.
Hearts were perfused with a modified Krebs-Henseleit
buffer at 100 cm H2O. Buffer composition was as follows
(in millimoles per liter, pH 7.4): NaCl 118, NaHCO3 24.8,
dextrose 10.0, KCl 4.7, CaCl2 2.5, KH2PO4 1.19, and
MgSO4 1.19. The buffer was filtered with a 0.45 mm
prefilter and a 5 mm in-line filter and bubbled with 95%
oxygen and 5% carbon dioxide. Perfusate temperature
was maintained at approximately 38° C except during the
hypothermic periods (described later). A temperature
probe was introduced into the right ventricular lumen for
continuous temperature measurement. A fluid-filled latex
balloon was placed inside the left ventricle (LV) and
attached to a pressure transducer for measurement of LV
pressure. Hearts were atrially paced at 270 beats/min
(model 58800, Grass Instruments, Quincy, Mass.). Total
coronary arterial perfusate flow was measured by timed
collection of effluent. Hearts were allowed to stabilize 15
minutes before the experimental protocol was begun.
Infarct size studies. Fifty-four hearts were assigned to
seven groups: normothermic control (CON), normother-
mic one-cycle preconditioning (IP1), normothermic four-
cycle preconditioning (IP4), 10-minute hypothermic con-
Fig. 1. Time line depicting the sequence of experimental manipulations. Black bars indicate periods of
hypothermia, stippled areas indicate periods of myocardial ischemia, and empty bars indicate periods of
normal perfusion.
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trol (H10), 10-minute hypothermia with one-cycle
preconditioning (H10 1 IP1), 40-minute hypothermic
control (H40), and 40-minute hypothermia with four-cycle
preconditioning (H40 1 IP4). A time line depicting the
experimental manipulations is presented in Fig. 1.
Induction of ischemia. Regional ischemia was elicited
by tightening the left coronary snare and was confirmed by
a decrease in total flow and a decrease in LV developed
pressure (LVDP). Reperfusion was accomplished by re-
lease of the snare and was verified by hyperemia and
partial resolution of the contractile dysfunction. All hearts
underwent 45 minutes of regional ischemia and 2 hours of
reperfusion. Ischemic preconditioning was elicited by
either one cycle of 5 minutes of regional ischemia begin-
ning 15 minutes before the 45-minute coronary occlusion
(IP1) or by four cycles of 5 minutes of regional ischemia
and 5 minutes of reperfusion beginning 45 minutes before
the 45-minute coronary occlusion (IP4).
Induction of hypothermia. Hypothermia (25° C) was
induced beginning either 20 or 50 minutes before the
45-minute period of regional ischemia; normothermia
(38° C) was restored 10 minutes before the 45-minute
coronary occlusion. Hypothermia was accomplished by
exchanging the warmed perfusate reservoir for a cooled
perfusate reservoir and by switching from a 38° C heated
water circulator perfusing the water-jacketed glassware
and tubing to a 25° C water circulator (model 8005, Fisher
Scientific, Pittsburgh, Pa.). Normothermia was accom-
plished by reexchanging the perfusate reservoirs and
circulators. The transition from normothermia to hypo-
thermia took less than 2 minutes to complete, and the
transition back to normothermia from hypothermic condi-
tions lasted from 3 to 5 minutes. Except for the hypothermic
periods already noted, hearts were maintained at 38° C.
Measurement of infarct size. At the conclusion of the
experiment, the coronary artery was reoccluded, and
Fig. 2. Infarct size data expressed as a percentage of the area at risk. A single cycle of normothermic
preconditioning ischemia resulted in infarct limitation, but a single cycle of hypothermic preconditioning
ischemia had no effect on infarct size. Profound cardioprotection was conferred by four-cycle precondi-
tioning, regardless of the absence or presence of hypothermia during preconditioning. Data are plotted as
mean 6 the standard error of the mean. Asterisks indicate statistically significant values compared with the
relevant control group (CON vs IP1, H10 vs H10 1 IP1, CON vs IP4, H40 vs H40 1 IP4). See text for
description of the groups.
Fig. 3. Comparison of glycogen (solid bars, left y-axis) and lactate (empty bars, right y-axis) levels in
myocardium subjected to either normothermia or hypothermia and to either no ischemia or a 5-minute
preconditioning ischemic period. Data are expressed as mean 6 the standard error of the mean. Single
asterisks indicate statistically significant values compared with CON group. Double asterisks indicate
statistically significant values compared with normothermic preconditioning. See text for description of the
groups.
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fluorescent particles (zinc cadmium sulfide, Duke Scien-
tific Corp., Palo Alto, Calif.) were infused into the aortic
root. The particles fluoresce bright yellow under ultravi-
olet light thereby delineating the risk area (previously
ischemic tissue) as a negative image. The heart was
removed from the Langendorff apparatus, weighed, and
frozen. The heart was then cut into transverse slices
approximately 2 mm thick and incubated in triphenyl
tetrazolium chloride (1% [wt/vol] in phosphate buffer at
37° C) for 20 minutes. Triphenyl tetrazolium chloride
produces a brick-red formazan pigment in viable myocar-
dium; necrotic myocardium does not stain and appears
whitish-tan. Risk and infarct areas were then traced. Risk
and infarct areas (in square centimeters) were determined
by computer-assisted planimetry, and the volume (in cubic
centimeters) of infarcted myocardium at risk was calcu-
lated from the planimetered areas and the slice thickness
(2 mm). All tissue processing, tracing, and planimetering
steps were performed in a blinded fashion. Hearts dem-
onstrating infarction outside of the risk area, or with a risk
area size of less than 0.4 cm3, were excluded from analysis.
Tissue glycogen and lactate studies. To evaluate the
metabolic effects of the hypothermia during the precon-
ditioning ischemic period, myocardial tissue glycogen and
lactate levels were determined in 12 separate hearts.
These hearts were randomly assigned to one of four
treatments: normothermia (n 5 3), normothermia with
one cycle of 5 minutes of global ischemia (n 5 3),
hypothermia (n 5 3), and hypothermia with one cycle of
5 minutes of global ischemia (n 5 3). Hypothermia was
instituted 5 minutes before induction of ischemia. At the
end of the ischemic period, or at 10 minutes of perfusion
in the absence of ischemia, the hearts were rapidly frozen
in liquid nitrogen.
Myocardial tissue glycogen levels were determined by
the enzymatic method of Keppler and Decker.8 Myocar-
dial tissue lactate levels were determined by an adaptation
of the methods of Fleischer9 and Gutmann and Wahl-
efeld.10 Determinations were performed in triplicate.
Data analysis. Temperature, heart rate, LV pressure,
and the electrocardiogram were recorded continuously on
a strip chart recorder (model RS3400, Gould Instruments,
Valley View, Ohio). Data were analyzed with a statistical
software package (Crunch version 4.07, Crunch Software,
Oakland, Calif.). Differences within groups were assessed
with one-way analysis of variance with the Dunnett post
hoc test for multiple comparisons. Differences between
groups in hemodynamics and infarct size as a percentage
of the risk area were analyzed with analysis of variance
with the Tukey post-hoc test. Differences between groups
in infarct volume were assessed with analysis of covari-
ance, with risk volume as the covariate. Data are ex-
pressed as means plus or minus the standard error of the
mean.
Results
Fifty-four hearts were entered into the infarct size
study; in 51 hearts the experimental protocol was
completed and the data were analyzed (CON 5 9,
Table I. LV pressures
Preconditioning
Baseline
Norm.
perf. IP
Norm.
perf. IP
Norm.
perf. IP
Norm.
perf. IP
Norm.
perf.
LVDP (mm Hg)
CON 98 6 3 99 6 3 97 6 3 92 6 3
IP1 94 6 4 91 6 5 32 6 3*† 71 6 4*†
H10 93 6 4 123 6 11* 128 6 9*† 78 6 4
H10 1 IP1 103 6 5 119 6 10 75 6 9*‡§ 82 6 7
IP4 87 6 3 86 6 4 36 6 2* 72 6 1* 35 6 4*\ 68 6 2*\ 35 6 4* 68 6 2*†\ 36 6 4*† 69 6 2*†
H40 99 6 4 99 6 11 115 6 12 110 6 6 112 6 8 111 6 7 113 6 6 110 6 8 110 6 8 92 6 9
H40 1 IP4 85 6 8 96 6 7 75 6 11¶ 131 6 21 78 6 8¶ 140 6 25 60 6 13¶ 111 6 24 54 6 12¶ 49 6 7¶
LVEDP (mm Hg)
CON 5 6 1 5 6 0 5 6 0 5 6 1
IP1 5 6 0 4 6 1 4 6 0 3 6 0*
H10 4 6 0 18 6 3*† 20 6 4*† 3 6 1
H10 1 IP1 5 6 0 21 6 4*‡ 15 6 3‡ 3 6 1
IP4 5 6 1 4 6 0 4 6 1 4 6 1 3 6 1 3 6 1* 3 6 0 3 6 1 3 6 1 2 6 0*†
H40 6 6 1 29 6 6* 25 6 6* 27 6 5* 25 6 6* 25 6 6* 27 6 8* 24 6 6*† 22 6 4*† 3 6 0
H40 1 IP4 6 6 1 23 6 5* 9 6 4 24 6 9* 12 6 7 15 6 6 5 6 2 17 6 6* 5 6 1¶ 3 6 1
Data within boxes reflect periods of hypothermia. See text for description of groups. Norm. Perf., Normal perfusion; IP, ischemic preconditioning.
*p , 0.05 vs baseline.
†p , 0.05 vs CON.
‡ , 0.05 vs. IP1.
§p , 0.05 vs H10.
\p , 0.05 vs H40 1 IP4.
¶p , 0.05 vs H40.
The Journal of Thoracic and
Cardiovascular Surgery
August 1998
3 2 2 Dote, Wolff, Van Winkle
IP1 5 9, IP4 5 4, H10 5 9, H10 1 IP1 5 10, H40 5
6, and H40 1 IP4 5 4). One heart was excluded
because of infarction outside of the risk area, one
heart was excluded because of a small risk area size
(,0.4 cm3), and one heart was excluded because of
a prolonged transfer and mounting time (.60 sec-
onds). There were no significant differences be-
tween groups in exclusions (p 5 0.86, x2). Twelve
hearts were entered into the myocardial glycogen
and lactate analyses; in all 12 the experimental
protocol was completed and the data were contrib-
uted to the data set.
Ventricular function and coronary flow. Ventric-
ular function and coronary perfusate flow were not
significantly different between groups at baseline
(before hypothermia and preconditioning ischemia).
LV end-diastolic pressure (LVEDP) and LVDP
data are shown in Table I. Both the preconditioning
ischemia and 45-minute ischemia resulted in a de-
crease in LVDP (except group H40 1 IP4, likely
because of variability in LVDP in the precondition-
ing reperfusion intervals). Reperfusion resulted in a
slight recovery in LVDP followed by maintenance of
this value over time; however, LVDP was still
significantly depressed compared with baseline val-
ues except in the H40 1 IP4 group.
The 45-minute period of ischemia, but not pre-
conditioning ischemia, resulted in a modest nonsig-
nificant gradual increase in LVEDP in all groups
compared with baseline. Reperfusion resulted in an
abrupt rise in LVEDP in all groups compared with
baseline (statistically significant in groups CON,
IP1, H10, and H10 1 IP1); this effect was less marked
in hearts that underwent four cycles of precondition-
ing (IP4 and H40 1 IP4 groups). Hypothermia itself
resulted in an increase in both LVDP (significant in
group H10) and LVEDP (significant in all hypother-
mic groups) during the hypothermic period.
Coronary perfusate flow data are shown in Table
II. Preconditioning ischemia resulted in an approx-
imately 40% decrease in coronary perfusate flow; in
the repetitive preconditioning groups (IP4 and H40
1 IP4) the decrease in flow during each cycle of
preconditioning ischemia was also approximately
40%, although there was a trend for the preischemic
flow values to decline with each preconditioning
cycle (statistically significant only for the fourth
preconditioning cycle). Hypothermia itself had no
effect on nonischemic flow as compared with the
baseline value.
During the period of hypothermia, hearts did not
follow the electrical pacemaker and heart rate fell
from the paced rate of 270 beats/min to 60 to 80
beats/min (p 5 0.0001). Thus heart rate was signif-
icantly different from baseline in all hypothermic
groups during the hypothermic period. However,
heart rate was comparable in the paired comparison
groups (H10 vs H10 1 IP1 and H40 vs H40 1 IP4) at
all times. Immediately on restoration of normother-
mia, hearts returned to the paced rate of 270
beats/min and at the time of the 45-minute occlusion
there were no differences in heart rate between the
groups.
Infarct size data. Heart weights and risk volumes
are shown in Table III. Infarct size data are depicted
in Fig. 2. There were no differences in biventricular
weight, risk volume, or the risk/biventricular weight
ratio between groups.
Normothermic ischemic preconditioning with ei-
ther one or four cycles of 5-minute coronary occlu-
sion resulted in a profound reduction of infarct size,
from 45.6% 6 9.1% in CON to 19.1% 6 4.7% in
IP1 and 2.5% 6 0.6% in IP4 hearts (p , 0.05 and
p , 0.01, respectively). The antecedent hypothermia
alone did not alter infarct size (CON 45.6% 6 9.1%
vs H10 41.0% 6 7.0% and H40 57.0% 6 8.1%; p 5
0.37). Hypothermic ischemic preconditioning with
one cycle of 5-minute coronary occlusion resulted in
no reduction of infarct size (H10 41.0% 6 7.0% vs
H10 1 IP1 43.1% 6 7.8%; p 5 0.33), but hypother-
mic ischemic preconditioning with four cycles of
5-minute coronary occlusion resulted in a profound
Occlusion Reperfusion
Start End Start Middle End
31 6 6* 55 6 3* 66 6 2* 71 6 2* 61 6 4*
29 6 3* 54 6 4* 71 6 4* 77 6 4* 68 6 6*
36 6 3* 59 6 3* 70 6 3* 76 6 3 67 6 4*
42 6 5* 56 6 5* 63 6 6* 64 6 6* 60 6 6*
33 6 2* 46 6 3* 61 6 2* 63 6 1* 58 6 2*
46 6 12* 58 6 9* 71 6 9 68 6 8 62 6 11*
26 6 7* 48 6 9 55 6 10 59 6 12 58 6 11
5 6 1 9 6 1 19 6 3* 14 6 2* 12 6 2*
4 6 1 6 6 1 14 6 1* 9 6 1* 7 6 1*
3 6 1 7 6 1 18 6 3* 13 6 2 14 6 3*
9 6 5 12 6 5 21 6 5* 17 6 6 17 6 6
3 6 0 4 6 1 7 6 1 4 6 1† 4 6 1
4 6 1 7 6 1 18 6 3 12 6 2 11 6 4
3 6 1 6 6 1 10 6 3 7 6 1 6 6 2
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reduction of infarct size, from 57.0% 6 8.1% in H40
to 3.3% 6 1.0% in H40 1 IP4 (p , 0.01). This
degree of cardioprotection was comparable to that
achieved with four cycles of normothermic precon-
ditioning.
Tissue glycogen and lactate data. As shown in
Fig. 3, normothermic 5-minute global ischemia re-
sulted in a profound increase of tissue lactate con-
tent (1.9 6 0.16 mmol/gm wet weight in normother-
mia vs 13.1 6 1.1 mmol/gm wet weight in
normothermia plus ischemia; p , 0.001). In con-
trast, hypothermic 5-minute global ischemia re-
sulted in no increase of tissue lactate content as
compared with that in nonischemic hypothermic
hearts (2.9 6 0.13 mmol/gm wet weight vs 1.7 6 0.22
mmol/gm wet weight, respectively; p 5 0.26). Hypo-
thermia alone did not alter myocardial tissue lactate
content (1.7 6 0.22 mmol/gm wet weight hypother-
mia vs 1.9 6 0.16 mmol/gm wet weight normother-
mia; p 5 0.35).
Normothermic ischemic preconditioning of 5
minutes of global ischemia resulted in a 67% reduc-
tion of tissue glycogen content as compared with
that of nonischemic normothermic hearts (1.6 6
0.28 mg/gm wet weight vs 4.8 6 0.15 mg/gm wet
weight, respectively; p , 0.001). Hypothermic isch-
emic preconditioning with 5 minutes of global isch-
emia resulted in no reduction of tissue glycogen
content (5.0 6 0.43 mg/gm wet weight hypothermia
vs 4.6 6 0.37 mg/gm wet weight hypothermia plus
ischemia; p 5 0.43). Hypothermia alone did not
alter myocardial tissue glycogen content (5.0 6 0.43
mg/gm wet weight hypothermia vs 4.8 6 0.15 mg/gm
wet weight normothermia; p 5 0.44).
Discussion
The present data show that preischemic hypother-
mia (25° C) alone does not affect infarct size, but
hypothermia during preconditioning ischemia in-
creases the threshold of ischemia necessary to elicit
cardioprotection. Thus, whereas a single 5-minute
period of normothermic coronary occlusion was
sufficient to induce preconditioning, multiple
5-minute periods of hypothermic coronary occlu-
sions were required to induce preconditioning. Ad-
ditionally, the maintenance of tissue glycogen and
lactate levels near control levels during the hypo-
thermic preconditioning coronary occlusion sug-
gests that despite a cessation of arterial perfusion
the tissue was not profoundly ischemic.
Normothermic preconditioning. Although isch-
emic preconditioning was originally observed after
repetitive coronary occlusions in the dog,3 subse-
quent canine studies have shown that a single occlu-
sion of 5 minutes confers cardioprotection compa-
rable to that elicited with multiple preconditioning
periods.11, 12 Similarly, in in situ rabbit hearts a
single 5-minute occlusion has been shown to be
equipotent with two 5-minute coronary occlusions in
preconditioning the myocardium.4 However, two
2-minute periods of coronary occlusion were insuf-
ficient to elicit preconditioning. In isolated rabbit
hearts previous investigators have successfully
elicited preconditioning with a single 5-minute
coronary occlusion.13-15 In the present study we
compared one and four 5-minute occlusions and
found that both paradigms produced infarct limi-
tation, although the four 5-minute coronary oc-
clusions produced a more robust cardioprotective
Table II. Total coronary flow (in milliliters per minute)
Preconditioning
Baseline
Norm.
perf. IP
Norm.
perf. IP
Norm.
perf. IP
Norm.
perf. IP
Norm.
perf.
CON 54 6 1 56 6 2 55 6 2 55 6 3
IP1 55 6 3 54 6 3 30 6 2*† 48 6 3*
H10 54 6 3 50 6 4 47 6 3 41 6 2*†
H10 1 IP1 54 6 2 52 6 4 31 6 2*‡ 45 6 4*
IP4 59 6 4 57 6 3 36 6 2* 56 6 5 34 6 3* 50 6 4* 32 6 3* 49 6 5*§ 32 6 3*†§ 46 6 3*
H40 63 6 3 66 6 3 62 6 2 59 6 4 52 6 4 49 6 4* 47 6 4* 44 6 4*† 42 6 4*† 52 6 5*
H40 1 IP4 50 6 2\ 54 6 4 34 6 3*\ 51 6 7 29 6 3*\ 42 6 7 23 6 3*\ 33 6 4* 19 6 1*\ 34 6 2*\
Data within boxes reflect periods of hypothermia. See text for description of groups. Norm. Perf., Normal perfusion; IP, ischemic preconditioning.
*p , 0.05 vs baseline.
†p ,0.05 vs CON.
‡p ,0.05 vs. H10.
§p ,0.05 vs H40 1 IP4.
\p ,0.05 vs H40.
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effect. Therefore, in normothermic rabbit hearts,
the threshold duration of coronary occlusion nec-
essary to elicit preconditioning is approximately 5
minutes and there appears to be a temporal
duration “dose-response” in eliciting the precon-
ditioning effect.
Ischemia during hypothermia. Moderate to pro-
found hypothermia prolongs organ survival during
global ischemia.16 Previous studies have demon-
strated a reduction of infarct size with hypothermia
(25° C),17, 18 and recently it was reported that mild
hypothermia (34° C) limits myocardial infarct size.2
The preservation of postischemic ventricular func-
tion conferred by normothermic preconditioning is
additive to the protection resulting from hypother-
mia during sustained ischemia.7 The converse situ-
ation—hypothermic preconditioning ischemia and
normothermic sustained ischemia—has not previ-
ously been studied. The present study demonstrates
that, rather than augmenting the protective effect of
preconditioning ischemia, hypothermia instead in-
creases the threshold of ischemia necessary to elicit
cardioprotection.
Myocardial metabolism and oxygen consumption
are decreased during hypothermia,16, 19 and the
oxygen consumption of arrested dog hearts cooled
to a temperature of 15° C is about 70% of that of
normothermic arrested hearts.20 Hypothermia is
associated with a significant decrease in the rate of
high-energy phosphate depletion and lactate pro-
duction that occurs in ischemic tissue.21 Similarly,
hypothermic arrest of dog hearts cooled to 17° C
results in a threefold slower decline in adenosine
triphosphate levels compared with results with nor-
mothermic potassium citrate arrest.19, 22 Hearts ar-
rested during hypothermia (17° C) use one forth less
glycogen and produce one third less lactate than
hearts arrested at normothermia.19, 22 These studies
suggest that both the basal and working metabolic
demands of hypothermic hearts are less than those
of normothermic hearts.
How does hypothermia increase the threshold
for ischemic preconditioning? Although there are
many definitions of ischemia, one common defi-
nition characterizes ischemia as a condition in
which oxygen and substrate delivery to the myo-
cardium is reduced to an extent that results in a
shift from aerobic to anaerobic metabolism.23
Given this definition, the hypothermic isolated
hearts in the current study were not markedly
ischemic inasmuch as glycogen stores were not
depleted and lactate was not produced. These
data suggest that despite a cessation of perfusion,
the balance between oxygen/substrate supply and
metabolic demand was not greatly perturbed,
likely because demand was also drastically re-
duced. Thus, because profound ischemia did not
exist during the single hypothermic precondition-
ing occlusion, there was no cellular signal to
initiate the preconditioning process.
Summary and conclusions
In summary, this study demonstrates that al-
though antecedent hypothermia does not alter myo-
cardial infarct size, it does increase the amount of
transient antecedent ischemia necessary to elicit
ischemic preconditioning.
We gratefully acknowledge the assistance of Michiko
Dote in the preparation of the manuscript.
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